お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
市場調査レポート
商品コード
918133

大腸癌治療薬の世界市場:2020年

Colorectal Cancer Drugs Global Market Report 2020

出版日: 受注生産 | 発行: The Business Research Company | ページ情報: 英文 | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
大腸癌治療薬の世界市場:2020年
出版日: 受注生産
発行: The Business Research Company
ページ情報: 英文
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の大腸癌治療薬市場について調査分析し、市場の特徴、市場規模と成長率、市場区分、地域・国別分析、競合情勢、市場シェア、動向、戦略などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場規模と成長

  • 市場実績、2015年~2019年(10億ドル)
    • 市場の成長要因
    • 市場の阻害要因
  • 市場予測、2019年~2022年、2025年、2030年(10億ドル)
    • 市場の成長要因
    • 市場の阻害要因

第4章 市場セグメンテーション

  • 治療薬のタイプ別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)
    • 血管内皮増殖因子(VEGF)阻害剤
    • 上皮成長因子受容体(EGFR)阻害剤
    • プログラム細胞死タンパク質1 / PD1リガンド1(PD1 / PDL1)阻害剤
    • BRAFまたはMEK阻害剤
    • チロシンキナーゼ(TKI)阻害剤
    • 免疫調節薬
  • 流通チャネル別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)
    • 病院薬局
    • 小売薬局
    • その他

第5章 地域および国別分析

  • 地域別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)
  • 国別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)

第6章 アジア太平洋地域市場

  • 市の概要
  • 治療薬タイプ別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)
  • 流通チャネル別市場、実績および予測、2015年~2022年、2025年、2030年(10億ドル)

第7章 中国市場

第8章 インド市場

第9章 日本市場

第10章 オーストラリア市場

第11章 インドネシア市場

第12章 韓国市場

第13章 西欧市場

第14章 英国市場

第15章 ドイツ市場

第16章 フランス市場

第17章 東欧市場

第18章 ロシア市場

第19章 北米市場

第20章 米国市場

第21章 南米市場

第22章 ブラジル市場

第23章 中東市場

第24章 アフリカ市場

第25章 市場競争情勢および企業プロファイル

  • 市場競争環境
  • 企業概要
    • Merck & Co. Inc
    • Roche
    • Sanofi
    • Amgen
    • PFIZER, INC.

第26章 市場における主要なM&A

第27章 市場動向と戦略

第28章 製品パイプライン分析

第29章 市場の将来展望と潜在力分析

第30章 付録

  • 略語
  • 通貨
  • 調査に関するお問い合わせ
  • The Business Research Company
  • 著作権および免責事項
目次

Colorectal Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global colorectal cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the colorectal cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Colorectal Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Type : Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators 2) By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Others

Companies Mentioned: Merck & Co. Inc, Roche, Sanofi, Amgen, PFIZER, INC.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Drugs Market Characteristics

3. Colorectal Cancer Drugs Market Size And Growth

  • 3.1. Global Colorectal Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Colorectal Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Colorectal Cancer Drugs Market Segmentation

  • 4.1. Global Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Vascular Endothelial Growth Factor (VEGF) Inhibitors
    • Epidermal Growth Factor Receptor (EGFR) Inhibitors
    • Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
    • BRAF or MEK Inhibitors
    • Tyrosine Kinase (TKI) Inhibitors
    • Immunomodulators
  • 4.2. Global Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospitals Pharmacies
    • Retail Pharmacies
    • Others

5. Colorectal Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Colorectal Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Colorectal Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Colorectal Cancer Drugs Market

  • 6.1. Asia-Pacific Colorectal Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Colorectal Cancer Drugs Market

  • 7.1. China Colorectal Cancer Drugs Market Overview
  • 7.2. China Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Colorectal Cancer Drugs Market

  • 8.1. India Colorectal Cancer Drugs Market Overview
  • 8.2. India Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Colorectal Cancer Drugs Market

  • 9.1. Japan Colorectal Cancer Drugs Market Overview
  • 9.2. Japan Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Colorectal Cancer Drugs Market

  • 10.1. Australia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Colorectal Cancer Drugs Market

  • 11.1. Indonesia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Colorectal Cancer Drugs Market

  • 12.1. South Korea Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Colorectal Cancer Drugs Market

  • 13.1. Western Europe Colorectal Cancer Drugs Market Overview
  • 13.2. Western Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Colorectal Cancer Drugs Market

  • 14.1. UK Colorectal Cancer Drugs Market Overview
  • 14.2. UK Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Colorectal Cancer Drugs Market

  • 15.1. Germany Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Colorectal Cancer Drugs Market

  • 16.4. France Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Colorectal Cancer Drugs Market

  • 17.1. Eastern Europe Colorectal Cancer Drugs Market Overview
  • 17.2. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Colorectal Cancer Drugs Market

  • 18.1. Russia Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Colorectal Cancer Drugs Market

  • 19.1. North America Colorectal Cancer Drugs Market Overview
  • 19.2. North America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Colorectal Cancer Drugs Market

  • 20.1. USA Colorectal Cancer Drugs Market Overview
  • 20.2. USA Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Colorectal Cancer Drugs Market

  • 21.1. South America Colorectal Cancer Drugs Market Overview
  • 21.2. South America Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Colorectal Cancer Drugs Market

  • 22.1. Brazil Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Colorectal Cancer Drugs Market

  • 23.1. Middle East Colorectal Cancer Drugs Market Overview
  • 23.2. Middle East Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Colorectal Cancer Drugs Market

  • 24.1. Africa Colorectal Cancer Drugs Market Overview
  • 24.2. Africa Colorectal Cancer Drugs Market, Segmentation By Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Colorectal Cancer Drugs Market, Segmentation By Distribution Channels, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Colorectal Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Colorectal Cancer Drugs Market Competitive Landscape
  • 25.2. Colorectal Cancer Drugs Market Company Profiles
    • 25.2.1. Merck & Co. Inc
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Roche
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Sanofi
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Amgen
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. PFIZER, INC.
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Colorectal Cancer Drugs Market

27. Colorectal Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Colorectal Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.